Market revenue in 2022 | USD 27.4 million |
Market revenue in 2030 | USD 34.8 million |
Growth rate | 3% (CAGR from 2022 to 2030) |
Largest segment | Antimicrobial |
Fastest growing segment | Antimicrobial |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Antimicrobial, Antibiotics |
Key market players worldwide | Boehringer Ingelheim, CEVA Inc, Elanco Animal Health Inc, Neogen Corp, Phibro Animal Health Corp Class A, Vetoquinol SA, Virbac SA, Zoetis Inc Class A |
Antimicrobial was the largest segment with a revenue share of 63.87% in 2022. Horizon Databook has segmented the Middle East & Africa animal antimicrobial and antibiotics market based on antimicrobial, antibiotics covering the revenue growth of each sub-segment from 2018 to 2030.
South Africa and Saudi Arabia are some of the most prominent animal antimicrobial and antibiotic market across the MEA region. Majority of the African countries are considered as an important source different agricultural commodities.
According to South Africa Poultry Association, in 2020 the poultry sector in South Africa was accountable for 41% of the country's total animal product gross value and 18% of the country's overall agricultural gross value.
The growing poultry industry in South Africa is boosting market for antimicrobial and antibiotic as antimicrobials are widely used for disease prevention and growth promotion in food animals. Various companies such as Boehringer Ingelheim Animal Health have been investing in research & development in the region to create customized animal antimicrobial and antibiotics products.
Key Regions: U.S. , Japan , Brazil , South Africa , Saudi Arabia
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account